Dai et al. reported that dietary-induced changes in cellular bioenergetics enhance the efficacy of anti-CTLA-4 immunotherapy by downregulating PD-L1 expression and upregulating type I interferon and antigen-presentation pathways, leading to prolonged survival in syngeneic murine tumor models [181]. This evidence concerns the gene CD274 and neoplasm.